2001
DOI: 10.1016/s0002-9149(00)01503-4
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
72
2
2

Year Published

2004
2004
2019
2019

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(82 citation statements)
references
References 13 publications
5
72
2
2
Order By: Relevance
“…14,15 Oral dipyridamole therapy has been shown to normalize the flow in patients with CSFP. 16 However, questions have been raised whether the normalization of the coronary flow could in fact be due to the effect of the medicine, or caused by the remission since CTFC improved but did not become normal in patients who had repeat angiography without any treatment, as observed by Beltrame. 9 354 Clin.…”
Section: Discussionmentioning
confidence: 99%
“…14,15 Oral dipyridamole therapy has been shown to normalize the flow in patients with CSFP. 16 However, questions have been raised whether the normalization of the coronary flow could in fact be due to the effect of the medicine, or caused by the remission since CTFC improved but did not become normal in patients who had repeat angiography without any treatment, as observed by Beltrame. 9 354 Clin.…”
Section: Discussionmentioning
confidence: 99%
“…They proposed that histopathologic abnormalities in microvascular structures cause or at least facilitate the increase in microvascular resistance. Later, Kurtoglu, et al, 22) using a TFC method, showed that dipyridamole, which has a vasodilator effect on microvascular coronary arteries, normalized SCF. Goel, et al 23) showed that definitively positive exercise testing was more common in SCF than in the normal coronary flow group.…”
Section: Discussionmentioning
confidence: 99%
“…Since its original description by Tambe et al in 1972, only scarce attention has been paid to this phenomenon and, consequently, its clinical significance has remained unclear. Some authors suggested that abnormal increase of small vessel resistance was the cause of the slow dye progression in selective coronary angiography (20)(21)(22). It is believed to represent coronary microvascular dysfunction.…”
Section: Discussionmentioning
confidence: 99%